RELATING TO STATE AFFAIRS AND GOVERNMENT -- QUASI-PUBLIC, CORPORATIONS ACCOUNTABILITY AND TRANSPARENCY ACT
Impact
This bill significantly impacts state laws concerning the financial operations of quasi-public entities. By restricting the movement of funds, S2357 seeks to fortify the operational stability of essential service providers by assuring that their collected revenues are used solely for their designated public functions. This change aims to prevent financial mismanagement or the misallocation of essential resources, which could hinder the services that Rhode Island residents depend on from these quasi-public corporations.
Summary
S2357 aims to enhance the accountability and transparency of quasi-public corporations in Rhode Island by imposing strict limitations on the transfer and reallocation of funds collected by these entities. The bill specifically stipulates that funds gathered by quasi-public agencies, which perform essential government functions, must remain with those entities and cannot be diverted to the state's general fund or other agencies. This legislative measure is designed to ensure that quasi-public corporations maintain autonomy over their financial resources, promoting responsible fiscal management and governance.
Contention
Notably, potential points of contention regarding S2357 may arise from discussions around government oversight and fiscal flexibility. Proponents argue that the bill promotes greater transparency and fiscal responsibility within quasi-public corporations, addressing the concerns of public scrutiny over how these entities manage substantial financial resources. Conversely, critics may contend that such restrictions could limit the government's ability to address broader fiscal needs or emergencies, where funds from these corporations might be necessary for immediate state budgetary concerns.
Provides that funds or monies collected by designated quasi-public corporations or agencies not be subject to transfer or reallocation by order of the governor or general assembly.
Provides that compensation comparability studies of senior management, documents discussed at an open meeting, annual contracting reports, list of current salaries and positions, and all policies and procedures of public corporations be made public.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Provides that funds or monies collected by designated quasi-public corporations or agencies not be subject to transfer or reallocation by order of the governor or general assembly.